Pemigatinib
About
Therapy type: Targeted therapy
Therapy strategy: FGFR inhibition
Mappings
NCI Thesaurus: Pemigatinib (coding:ncit:C121553)
RxNorm: pemigatinib (coding:rxcui:2359268, coding:omop:37499576)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | FGFR2::v | Cholangiocarcinoma | Pemigatinib | |
| FDA (2) | FGFR2 rearrangements | Cholangiocarcinoma | Pemigatinib | |
| FDA (2) | FGFR1 rearrangements | Myeloid Neoplasm | Pemigatinib | |
| FDA (2) | FGFR1 rearrangements | Lymphocytic Neoplasm | Pemigatinib |